In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer

Cancer Biomarkers · Published 2026-06-01 · DOI 10.1177/18758592261463305

Free full text

Authors (7)

Kiarash Zare, Zahra Salehi, Ali Reza Morovat, Ali Aghajani, Pardis Mohammadi Pour, Ali Ghanbariasad, Mohammad Mehdi Naghizadeh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zare, K., Salehi, Z., Morovat, A., et al. (2026). In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer. Cancer Biomarkers. https://doi.org/10.1177/18758592261463305

Related articles

• A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study · Cancer Biomarkers · 2026 · Same journal
• Serum exosomal miR-1275 as a potential biomarker for the diagnosis and prognostic assessment of hepatocellular carcinoma · Cancer Biomarkers · 2025 · Same journal
• Multi-cancer early detection tests: Attributes for clinical implementation · Cancer Biomarkers · 2025 · Same journal
• Systematic exploration of prognostic alternative splicing events related to tumor immune microenvironment of Clear Cell Renal Cell Carcinoma · Cancer Biomarkers · 2025 · Same journal
• Panax notoginseng improves the sensitivity of non-small cell lung cancer to cisplatin by inhibiting Akt signaling · Cancer Biomarkers · 2025 · Same journal
• Role of immune cell subsets in liver fibrosis through single-cell RNA sequencing and array · Cancer Biomarkers · 2025 · Same journal
• Identifying diagnostic markers and establishing prognostic model for lung cancer based on lung cancer-derived exosomal genes · Cancer Biomarkers · 2025 · Same journal
• The effect of low-intensity resistance exercise training on Serum tumor biomarkers and quality of life in women with breast cancer: A randomized controlled trial · Cancer Biomarkers · 2025 · Same journal
• The overexpression of HOXC6 in LUSC and pan-squamous cell carcinomas indicates the coexistence of nuclear division regulatory mechanisms · Cancer Biomarkers · 2025 · Same journal
• Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma · Cancer Biomarkers · 2025 · Same journal